review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Hermelijn H Smits | Q58454795 |
P2093 | author name string | P S Hiemstra | |
R Gerth van Wijk | |||
E C de Jong | |||
C Taube | |||
A L Voskamp | |||
T Groot Kormelink | |||
P2860 | cites work | Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum | Q24594356 |
Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9 | Q24651071 | ||
Single-cell technologies are revolutionizing the approach to rare cells | Q26775923 | ||
ICOS Co-Stimulation: Friend or Foe? | Q28072305 | ||
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils | Q28190702 | ||
Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor | Q30525273 | ||
Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells | Q33770015 | ||
Microbial 'old friends', immunoregulation and socioeconomic status. | Q33871387 | ||
Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells | Q33949038 | ||
Enhanced innate type 2 immune response in peripheral blood from patients with asthma | Q34111924 | ||
Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines | Q34364735 | ||
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma | Q34446514 | ||
Resident CD11b(+)Ly6C(-) lung dendritic cells are responsible for allergic airway sensitization to house dust mite in mice | Q34541807 | ||
The murine Th2 locus undergoes epigenetic modification in the thymus during fetal and postnatal ontogeny | Q34555637 | ||
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation | Q34580221 | ||
The influence of the microbiome on respiratory health | Q90003618 | ||
Role of Biologics in Asthma | Q90333130 | ||
Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial | Q91248856 | ||
Associations between fungal and bacterial microbiota of airways and asthma endotypes | Q91671586 | ||
Human Dendritic Cell Subsets, Ontogeny, and Impact on HIV Infection | Q92479178 | ||
Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids | Q92524217 | ||
Epithelial cell-derived cytokines: more than just signaling the alarm | Q92744570 | ||
Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma | Q92765247 | ||
Thinking bigger: How early-life environmental exposures shape the gut microbiome and influence the development of asthma and allergic disease | Q92970146 | ||
Extract of Helicobacter pylori Ameliorates Parameters of Airway Inflammation and Goblet Cell Hyperplasia following Repeated Allergen Exposure | Q93047905 | ||
Dendritic Cells and Cancer: From Biology to Therapeutic Intervention | Q93060366 | ||
Dendritic cell subsets in T cell programming: location dictates function | Q93338385 | ||
OX40L blockade and allergen-induced airway responses in subjects with mild asthma | Q34620982 | ||
Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4 | Q34638212 | ||
Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract | Q34930189 | ||
Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development | Q35599871 | ||
Distinct signal codes generate dendritic cell functional plasticity | Q35887479 | ||
Opposing Roles of Dectin-1 Expressed on Human Plasmacytoid Dendritic Cells and Myeloid Dendritic Cells in Th2 Polarization | Q35931761 | ||
Microbes and asthma: Opportunities for intervention | Q35947135 | ||
Neonatal innate TLR-mediated responses are distinct from those of adults. | Q36015806 | ||
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response | Q36062377 | ||
AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch | Q36309139 | ||
Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. | Q36376225 | ||
Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization | Q36403250 | ||
Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12 | Q36455290 | ||
Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance | Q36637575 | ||
Vitamin D regulation of OX40 ligand in immune responses to Aspergillus fumigatus | Q36826916 | ||
Migratory properties of pulmonary dendritic cells are determined by their developmental lineage | Q36840567 | ||
IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses | Q36882237 | ||
Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity | Q36916344 | ||
Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance | Q36960928 | ||
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice | Q37156531 | ||
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway | Q37175226 | ||
Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species | Q37293474 | ||
Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic cell and monocyte fate. | Q37534064 | ||
Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis. | Q37619448 | ||
Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. | Q37730878 | ||
The role of Helicobacter pylori infection in the development of allergic asthma | Q38042722 | ||
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations | Q38224936 | ||
Microorganism-induced suppression of allergic airway disease: novel therapies on the horizon? | Q38241379 | ||
The role of FcεRI expressed in dendritic cells and monocytes | Q38365223 | ||
Treatment of severe asthma: entering the era of targeted therapy | Q38578918 | ||
D-tryptophan from probiotic bacteria influences the gut microbiome and allergic airway disease | Q38743667 | ||
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. | Q38872144 | ||
Mechanical Bacterial Lysate Administration Prevents Exacerbation in Allergic Asthma Children - The EOLIA Study. | Q52633796 | ||
Dectin-2 promotes house dust mite-induced T helper type 2 and type 17 cell differentiation and allergic airway inflammation in mice. | Q52767065 | ||
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency. | Q52812457 | ||
Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite. | Q53084576 | ||
Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. | Q53085315 | ||
Mouse lung CD103+ and CD11bhigh dendritic cells preferentially induce distinct CD4+ T-cell responses. | Q53220402 | ||
Persistence of asthma following allergen avoidance is associated with proTh2 myeloid dendritic cell activation. | Q53457230 | ||
Coexpression of type 2 immune targets in sputum-derived epithelial and dendritic cells from asthmatic subjects. | Q53568393 | ||
Solitary Chemosensory Cells are a Primary Epithelial Source of Interleukin-25 in Chronic Rhinosinusitis with Nasal Polyps. | Q54108644 | ||
Dectin-1/2-induced autocrine PGE2 signaling licenses dendritic cells to prime Th2 responses. | Q54115496 | ||
Anticalin® Proteins as Therapeutic Agents in Human Diseases. | Q55484632 | ||
Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence. | Q55714629 | ||
ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses | Q56905108 | ||
Identification of a Novel OX40L Dendritic Cell Subset That Selectively Expands Regulatory T cells | Q57296151 | ||
High levels of Butyrate and Propionate in early life are associated with protection against atopy | Q58613362 | ||
Eosinophil recruitment is dynamically regulated by interplay among lung dendritic cell subsets after allergen challenge | Q58700591 | ||
Stereotypic Immune System Development in Newborn Children | Q58713494 | ||
Isolated Schistosoma mansoni eggs prevent allergic airway inflammation | Q58735466 | ||
Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration | Q58786962 | ||
The hygiene hypothesis: immunological mechanisms of airway tolerance | Q58790648 | ||
Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells | Q59352186 | ||
Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules | Q59792550 | ||
Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma | Q60627303 | ||
High-Affinity IgE Receptors on Dendritic Cells Exacerbate Th2-Dependent Inflammation | Q61715953 | ||
IL ‐33 signalling contributes to pollutant‐induced allergic airway inflammation | Q61756868 | ||
Worms: Pernicious parasites or allies against allergies? | Q62589126 | ||
Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals | Q63362699 | ||
Role of innate lymphoid cells in allergic diseases | Q64072583 | ||
Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response | Q73470671 | ||
Cutting edge: Th2 response induction by dendritic cells: a role for CD40 | Q77452185 | ||
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis | Q79189373 | ||
Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis | Q80465298 | ||
Mite allergen decreases DC-SIGN expression and modulates human dendritic cell differentiation and function in allergic asthma | Q83799822 | ||
The immunostimulant OM-85 BV prevents wheezing attacks in preschool children | Q85155651 | ||
Rapid recruitment of CD14(+) monocytes in experimentally induced allergic rhinitis in human subjects | Q87241472 | ||
Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses | Q88006050 | ||
Immunomodulatory innate defence regulator (IDR) peptide alleviates airway inflammation and hyper-responsiveness | Q88938581 | ||
Asthma | Q89218803 | ||
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells | Q89776801 | ||
First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment | Q38947692 | ||
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. | Q39000691 | ||
Proteolytic antigens interfere with endosome/lysosome fusion in epithelial cells. | Q39064127 | ||
A randomized multicenter study evaluating Xolair persistence of response after long-term therapy | Q39203449 | ||
Mouse models of severe asthma: Understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation | Q39237092 | ||
Notch Signaling in T Helper Cell Subsets: Instructor or Unbiased Amplifier? | Q39274325 | ||
Hookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma | Q39296277 | ||
Interplay between barrier epithelial cells and dendritic cells in allergic sensitization through the lung and the skin | Q39402927 | ||
Innate and adaptive type 2 immunity in lung allergic inflammation. | Q39402938 | ||
Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. | Q39465399 | ||
Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy | Q40096295 | ||
Schistosome egg antigens, including the glycoprotein IPSE/alpha-1, trigger the development of regulatory B cells. | Q40115518 | ||
The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice. | Q40125256 | ||
Chronic schistosomiasis during pregnancy epigenetically reprograms T-cell differentiation in offspring of infected mothers | Q40303253 | ||
Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation? | Q41352500 | ||
The placebo effect in allergen-specific immunotherapy trials | Q41846193 | ||
Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells | Q41865349 | ||
25-hydroxvitamin D3 promotes the long-term effect of specific immunotherapy in a murine allergy model | Q42209528 | ||
Lung CD103+ dendritic cells restrain allergic airway inflammation through IL-12 production | Q42257941 | ||
HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33 | Q42635953 | ||
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. | Q42972510 | ||
Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen | Q43468956 | ||
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma | Q43867936 | ||
The proteolytic activity of the major dust mite allergen Der p 1 conditions dendritic cells to produce less interleukin-12: allergen-induced Th2 bias determined at the dendritic cell level | Q44173550 | ||
Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis | Q44240760 | ||
Tezepelumab in Adults with Uncontrolled Asthma | Q46786993 | ||
A structurally distinct TGF-β mimic from an intestinal helminth parasite potently induces regulatory T cells. | Q47110589 | ||
CRTH2 antagonists in asthma: current perspectives | Q47119852 | ||
Broncho-Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta-analysis | Q47446260 | ||
Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion | Q47561020 | ||
Plasmacytoid dendritic cells drive acute asthma exacerbations | Q47605453 | ||
IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. | Q47765771 | ||
Severe and Difficult-to-Treat Asthma in Adults | Q47848891 | ||
The longitudinal impact of probiotic and peanut oral immunotherapy on health-related quality of life | Q48157630 | ||
Therapeutic Application of an Extract of Helicobacter pylori Ameliorates the Development of Allergic Airway Disease | Q48204929 | ||
The Schistosoma mansoni T2 ribonuclease omega-1 modulates inflammasome-dependent IL-1β secretion in macrophages | Q48512810 | ||
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study | Q48650567 | ||
Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung. | Q49131456 | ||
Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation | Q49912179 | ||
Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab. | Q50138296 | ||
IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. | Q50870116 | ||
Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin. | Q51040026 | ||
The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. | Q51542948 | ||
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. | Q51611177 | ||
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. | Q51813678 | ||
Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny | Q51895264 | ||
FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy. | Q52570866 | ||
Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation. | Q52631433 | ||
P433 | issue | 1 | |
P921 | main subject | allergic asthma | Q12301086 |
P304 | page(s) | 95-110 | |
P577 | publication date | 2020-02-04 | |
P1433 | published in | Seminars in Immunopathology | Q15724576 |
P1476 | title | Modulating local airway immune responses to treat allergic asthma: lessons from experimental models and human studies | |
P478 | volume | 42 |
Search more.